Delivery Order SPE2DB25D3306-SPE2DB25FUCPD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,541.99 to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) on September 5, 2025, with completion scheduled for September 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TRIUMEQ is an antiretroviral combination therapy used for HIV treatment,...
- The Defense Logistics Agency awarded a delivery order valued at $12,886.43 to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) on August 4, 2025, with completion targeted for August 5, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,675.06 firm fixed-price delivery order for TRIUMEQ 600-50-300 mg tablets (30-unit pack) to be delivered to Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This is a non-set-aside competitive award issued as a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA Troop Support Medical. TRIUMEQ is an antiretroviral combination medication used in HIV...
- The Defense Logistics Agency awarded a $38,550.86 delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-unit packaging) with an ultimate completion date of August 14, 2025. This firm fixed-price contract represents a non-set-aside competitive award, with performance to be executed at the contractor's Conshohocken, Pennsylvania facility. TRIUMEQ is a prescription antiretroviral medication used in HIV treatment, indicating this delivery supports federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $8,910.52 to AmerisourceBergen Drug Corp for the supply of TRIUMEQ 600-50-300 mg tablets (30-count units) on September 4, 2025, with completion expected by September 5, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a $11,096.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) with a completion date of August 4, 2025. This competitively awarded, non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement extending through December 2026. The delivery will be performed...
- The Defense Logistics Agency awarded a delivery order valued at $24,294.69 to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count unit dose packages) on September 17, 2025, with a completion date of September 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TRIUMEQ is a fixed-dose combination antiretroviral medication used in the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) valued at $12,781.54 under a firm fixed price contract type. The award, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a competitively awarded, non-set-aside procurement. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, the company's corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. This delivery order, valued at $12,117.72, represents a firm fixed price contract with no set-aside designation, reflecting a competitively awarded transaction under open procurement standards. The contract is scheduled for ultimate completion on August 8, 2025, with performance taking place at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $10.87K delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) with a firm fixed price arrangement. The award, issued on May 30, 2025, represents a competitive, non-set-aside procurement with an ultimate completion date of June 2, 2025. TRIUMEQ is a combination antiretroviral medication used in HIV treatment, consistent with AmerisourceBergen's broader role as a critical pharmaceutical supplier to the federal...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCPDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $14,373.49 to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count unit dose packaging) on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office located in Conshohocken, Pennsylvania. TRIUMEQ is a combination antiretroviral medication used in HIV treatment, reflecting the Defense Logistics Agency's ongoing procurement of critical pharmaceutical products to support military and federal healthcare systems. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates significant capability in fulfilling diverse pharmaceutical procurement requirements across multiple therapeutic domains for defense and civilian federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.4k | 8/11/25 |